Clene Inc. (CLNN)
Nasdaq: CLNN · Pharmaceutical Preparations · Salt Lake City, UT · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 17, 2026 | Mar 24, 2025 | Mar 13, 2024 | Mar 13, 2023 | Mar 11, 2022 | Mar 29, 2021 | · |
| Revenue | 200 | 342 | 654 | 473 | 723 | 206 | · |
| For lenders | |||||||
| Net interest income | · | · | · | -3,296 | -870 | · | · |
| Cost of revenue | 43 | 70 | 121 | 26 | 289 | · | · |
| Research and development | 14,011 | 20,058 | 26,655 | 31,920 | 28,416 | 15,204 | 9,563 |
| General and administrative | 9,229 | 13,307 | 14,418 | 16,936 | 21,996 | 5,151 | 6,769 |
| Total operating expenses | · | · | · | · | 50,701 | 20,420 | 16,332 |
| Total costs and expenses | 23,283 | 33,435 | 41,194 | 48,882 | 50,701 | · | · |
| Operating income | -23,083 | -33,093 | -40,540 | -48,409 | -49,978 | -20,214 | -16,332 |
| Interest expense | 2,682 | 4,064 | 4,558 | 3,296 | 870 | 950 | 88 |
| Interest and investment income | 223 | 865 | 1,389 | 225 | · | · | · |
| Other income (expense), net | 0 | -1 | 10 | 32r | -12 | 34 | 27 |
| Total non-operating income (expense) | -3,090 | -6,307 | -8,964 | 18,491 | 39,810 | 1,343 | 177 |
| Income before income taxes | -26,173 | -39,400 | -49,504 | -29,918 | -10,168 | -18,871 | -16,155 |
| Income tax expense | 0 | 0 | 0 | 0 | -428 | 406 | · |
| Net income including non-controlling interests | · | · | · | · | -9,740 | -19,277 | -16,155 |
| Net income | -26,173 | -39,400 | -49,504 | -29,918 | -9,740 | -19,277 | -16,155 |
| Earnings per share, basic | -2.65 | -5.67 | -9.43r | -9.20b | -3.20b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -3.20b | -22.00b | -18.60b |
| Weighted average shares, basic | 9,858,907 | 6,954,133 | 5,246,941r | 3,260,233b | 3,077,923b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 3,077,923b | 875,200b | 867,875b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted